Skip to main content
All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for HALEON US HOLDINGS LLC · consumer health care company

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $50,000.00 income · posted Jul 19, 2026

Official filing document

 Bills named in this filing 1
  • HR 8495
    Financial Services and General Government Appropriations Act, 2027
 Lobbying activity 5
Health Issues

Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.

Taxation/Internal Revenue Code

Issues related to coverage of over-the-counter products with FSAs and HSAs.

Budget/Appropriations

Policies impacting access to over-the-counter products; FY2027 Financial Services and General Government Appropriations Act (H.R.8495).

Trade (domestic/foreign)

Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.

Medicare/Medicaid

Education about the importance of OTC products and benefits under Medicare Advantage.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem